Lymphoma

Top Story

Melanoma surveillance could benefit patients with chronic lymphocytic leukemia

Melanoma surveillance could benefit patients with chronic lymphocytic leukemia
November 5, 2018

HemOnc Today launches Cell Therapy Next

November 5, 2018
THOROFARE, NJ – With the approval of two chimeric antigen receptor T-cell therapies in the past year, the need arose for quality information and education about…

Rutgers Cancer Institute section chief receives distinguished service award

November 4, 2018
Richard Drachtman, MD, received the Distinguished Service Award from Melvyn H. Motolinsky Research Foundation, established to support research into leukemia and other…
In the Journals Plus

Combination shows promise in relapsed, refractory non-Hodgkin lymphoma

October 31, 2018
The combination of Hu5F9-G4 and rituximab demonstrated promising activity among patients with relapsed or refractory non-Hodgkin lymphoma, according to results of a…
More Headlines »
CME

Multimodality Treatment Strategies for NSCLC: A Symposium at the US Oncology Annual Meeting

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. Approximately 85% of diagnosed lung cancers are non-small…
More »
Video
Meeting News

VIDEO: Anti-CD47 fusion protein well tolerated by patients with solid tumors, non-Hodgkin lymphoma

June 24, 2018
More »
Resource Centers

CME

Virtual NSCLC: Updates in Combining Immunotherapy with Other Treatment Modalities

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be…
More »